Elly Sau Wai Sau-Wai Ngan

Prof. Elly Sau Wai Sau-Wai Ngan

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MGMaria-Mercè Garcia-Barcelo
Maria-Mercè Garcia-Barcelo
CTClara Sze-man TANG
Clara Sze-man TANG
ENElly Sau Wai Sau-Wai Ngan
Elly Sau Wai Sau-Wai Ngan
VLVincent Chi Hang Lui
Vincent Chi Hang Lui
YCYan Chen
Yan Chen
PTPaul Kwong-Hang Tam
Paul Kwong-Hang Tam
Hirschsprung's disease (HSCR), or aganglionic megacolon, is a congenital disorder characterized by the absence of enteric ganglia in variable portions of the distal intestine. RET is a well-established susceptibility locus, although existing evidence strongly suggests additional loci contributing to sporadic HSCR. To identify these additional genetic loci, we carried out a genome-wide association study using the Affymetrix 500K marker set. We successfully genotyped 293,836 SNPs in 181 Chinese subjects with sporadic HSCR and 346 ethnically matched control subjects. The SNPs most associated with HSCR were genotyped in an independent set of 190 HSCR and 510 control subjects. Aside from SNPs in RET , the strongest overall associations in plausible candidate genes were found for 2 SNPs located in intron 1 of the neuregulin1 gene ( NRG1 ) on 8p12, with rs16879552 and rs7835688 yielding odds ratios of 1.68 [CI 95% :(1.40, 2.00), P = 1.80 × 10 −8 ] and 1.98 [CI 95% :(1.59, 2.47), P = 1.12 × 10 −9 ], respectively, for the heterozygous risk genotypes under an additive model. There was also a significant interaction between RET and NRG1 ( P = 0.0095), increasing the odds ratio 2.3-fold to 19.53 for the RET rs2435357 risk genotype (TT) in the presence of the NRG1 rs7835688 heterozygote, indicating that NRG1 is a modifier of HSRC penetrance. Our highly significant association findings are backed-up by the important role of NRG1 as regulator of the development of the enteric ganglia precursors. The identification of NRG1 as an additional HSCR susceptibility locus not only opens unique fields of investigation into the mechanisms underlying the HSCR pathology, but also the mechanisms by which a discrete number of loci interact with each other to cause disease.

1 September 2016 in Developmental Biology
Verified
Journal Article
Open access
ABAlan J. Burns
Alan J. Burns
AGAllan M. Goldstein
Allan M. Goldstein
DNDonald F. Newgreen
Donald F. Newgreen
LSLincon Stamp
Lincon Stamp
KSKarl-Herbert Schäfer
Karl-Herbert Schäfer
PBPieter Vanden Berghe
Pieter Vanden Berghe
Over the last 20 years, there has been increasing focus on the development of novel stem cell based therapies for the treatment of disorders and diseases affecting the enteric nervous system (ENS) of the gastrointestinal tract (so-called enteric neuropathies). Here, the idea is that ENS progenitor/stem cells could be transplanted into the gut wall to replace the damaged or absent neurons and glia of the ENS. This White Paper sets out experts' views on the commonly used methods and approaches to identify, isolate, purify, expand and optimize ENS stem cells, transplant them into the bowel, and assess transplant success, including restoration of gut function. We also highlight obstacles that must be overcome in order to progress from successful preclinical studies in animal models to ENS stem cell therapies in the clinic.

11 May 2010 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
MGMaria-Mercè Garcia-Barceló
Maria-Mercè Garcia-Barceló
MYMing-Yiu Yeung
Ming-Yiu Yeung
XMXiao-Ping Miao
Xiao-Ping Miao
CTClara Sze-man TANG
Clara Sze-man TANG
GCGuo Chen
Guo Chen
PTPaul Kwong-Hang Tam
Paul Kwong-Hang Tam
Biliary atresia (BA) is characterized by the progressive fibrosclerosing obliteration of the extrahepatic biliary system during the first few weeks of life. Despite early diagnosis and prompt surgical intervention, the disease progresses to cirrhosis in many patients. The current theory for the pathogenesis of BA proposes that during the perinatal period, a still unknown exogenous factor meets the innate immune system of a genetically predisposed individual and induces an uncontrollable and potentially self-limiting immune response, which becomes manifest in liver fibrosis and atresia of the extrahepatic bile ducts. Genetic factors that could account for the disease, let alone for its high incidence in Chinese, are to be investigated. To identify BA susceptibility loci, we carried out a genome-wide association study (GWAS) using the Affymetrix 5.0 and 500 K marker sets. We genotyped nearly 500 000 single-nucleotide polymorphisms (SNPs) in 200 Chinese BA patients and 481 ethnically matched control subjects. The 10 most BA-associated SNPs from the GWAS were genotyped in an independent set of 124 BA and 90 control subjects. The strongest overall association was found for rs17095355 on 10q24, downstream XPNPEP1, a gene involved in the metabolism of inflammatory mediators. Allelic chi-square test P-value for the meta-analysis of the GWAS and replication results was 6.94 × 10−9. The identification of putative BA susceptibility loci not only opens new fields of investigation into the mechanisms underlying BA but may also provide new clues for the development of preventive and curative strategies.

16 September 2016 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
XWXiao Qi Wang
Xiao Qi Wang
CLChung Mau Lo
Chung Mau Lo
LCLin Chen
Lin Chen
ENElly Sau Wai Sau-Wai Ngan
Elly Sau Wai Sau-Wai Ngan
AXAimin Xu
Aimin Xu
RPRandy Yat Choi Poon
Randy Yat Choi Poon
The mechanisms of how signaling pathways are coordinated and integrated for the maintenance of the self-renewal of human embryonic stem cells (hESCs) and the acquisition of pluripotency in reprogramming are still only partly understood. CDK1 is a key regulator of mitosis. Recently, CDK1 has been shown to be involved in regulating self-renewal of stem cells, even though the mechanistic role of how CDK1 regulates pluripotency is unknown. In this report, we aim to understand how CDK1 can control pluripotency by reducing CDK1 activity to a level that has no effect on cell cycle progression. We demonstrated that high levels of CDK1 is associated with the pluripotency stage of hESCs; and decreased CDK1 activity to a level without perturbing the cell cycle is sufficient to induce differentiation. CDK1 specifically targets the phosphorylation of PDK1 and consequently the activity of PI3K/Akt and its effectors ERK and GSK3β. Evidence of the reversion of inactive CDK1-mediated differentiation by the inhibition of Akt signaling effectors suggests that the CDK1-PDK1-PI3K/Akt kinase cascade is a functional signaling pathway for the pluripotency of hESCs. Moreover, cyclin B1-CDK1 complexes promote somatic reprogramming efficiency, probably by regulating the maturation of induced pluripotent stem cells (iPSCs), as cyclin B1 stimulates a higher cellular level of LIN28A, suggesting that monitoring iPSC factors could be a new path for the enhancement of reprogramming efficiency. Together, we demonstrate an essential role for the CDK1-PDK1-PI3K/Akt kinase signaling pathway in the regulation of self-renewal, differentiation, and somatic reprogramming, which provides a novel kinase cascade mechanism for pluripotency control and acquisition.

4 February 2009 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
ENElly Sau Wai Sau-Wai Ngan
Elly Sau Wai Sau-Wai Ngan
BLBrian H. H. Lang
Brian H. H. Lang
TLTingting Liu
Tingting Liu
CSCathy K. Y. Shum
Cathy K. Y. Shum
MSMan-Ting So
Man-Ting So
MGMaria-Mercè Garcia-Barceló
Maria-Mercè Garcia-Barceló
The genetic factors that determine the risk of papillary thyroid carcinoma (PTC) among patients with multinodular goiter (MNG) remain undefined. Because thyroid transcription factor-1 (TTF-1) is important to thyroid development, we evaluated whether the gene that encodes it, TITF-1/NKX2.1, is a genetic determinant of MNG/PTC predisposition. Twenty unrelated PTC patients with a history of MNG (MNG/PTC), 284 PTC patients without a history of MNG (PTC), and 349 healthy control subjects were screened for germline mutation(s) in TITF-1/NKX2.1 by sequencing of amplified DNA from blood. The effects of the mutation on the growth and differentiation of thyroid cells were demonstrated by ectopic expression of wild-type (WT) and mutant proteins in PCCL3 normal rat thyroid cells, followed by tests of cell proliferation, activation of cell growth pathways, and transcription of TTF-1 target genes. All statistical tests were two-sided. A missense mutation (1016C>T) was identified in TITF-1/NKX2.1 that led to a mutant TTF-1 protein (A339V) in four of the 20 MNG/PTC patients (20%). These patients developed substantially more advanced tumors than MNG/PTC or PTC patients without the mutation (P = .022, Fisher exact test). Notably, this germline mutation was dominantly inherited in two families, with some members bearing the mutation affected with MNG, associated with either PTC or colon cancer. The mutation encoding the A339V substitution was not found among the 349 healthy control subjects nor among the 284 PTC patients who had no history of MNG. Overexpression of A339V TTF-1 in PCCL3 cells, as compared with overexpression of WT TTF-1, was associated with increased cell proliferation including thyrotropin-independent growth (average A339V proliferation rate = 134.27%, WT rate = 104.43%, difference = 34.3%, 95% confidence interval = 12.0% to 47.7%, P = .010), enhanced STAT3 activation, and impaired transcription of the thyroid-specific genes Tg, TSH-R, and Pax-8. This is the first germline mutation identified in MNG/PTC patients. It could contribute to predisposition for MNG and/or PTC and to the pathogenesis of PTC.

1 October 2018 in Journal of Hepatology
Verified
Journal Article
Closed access
MTMan Tong
Man Tong
NCNoélia Che
Noélia Che
LZLei Zhou
Lei Zhou
SLSteve T. Luk
Steve T. Luk
PKPhillis W. Kau
Phillis W. Kau
SMStephanie KY Ma
Stephanie KY Ma